Search

Your search keyword '"Colomba, E."' showing total 29 results

Search Constraints

Start Over You searched for: Author "Colomba, E." Remove constraint Author: "Colomba, E." Publisher elsevier b.v. Remove constraint Publisher: elsevier b.v.
29 results on '"Colomba, E."'

Search Results

1. P182 - IO-Synthesise RCC: relationship between baseline health-related quality of life and clinical outcomes of nivolumab in patients with previously treated metastatic renal cell carcinoma using pooled real-world data from France and Germany

2. Individual and combined effects of drought and heat on antioxidant parameters and growth performance in Buffel grass (Cenchrus ciliaris L.) genotypes.

3. Spécificités cliniques des tumeurs de vessie n'infiltrant pas le muscle métastatique d'emblée : étude observationnelle multicentrique merinos.

4. 1480P Baseline levels of proinflammatory cytokines according to body mass index (BMI) and BMI impact on clinical outcomes in metastatic renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (NIVO) within the NIVOREN trial.

5. 603P Objective computerized cognitive assessment in men with metastatic castrate-resistant prostate cancer (mCRPC) randomly receiving darolutamide or enzalutamide in the ODENZA trial.

6. Differential salt-stress response during germination and vegetative growth in in vitro selected somaclonal mutants of Cenchrus ciliaris L.

12. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.

16. 20MO Time to deterioration in quality of life in patients (pts) with advanced endometrial cancer (aEC) treated with lenvatinib plus pembrolizumab (L+P) or treatment of physician's choice (TPC).

17. 1762P MERINOS: Metastatic non muscle invasive urothelial carcinoma - An observational study.

18. 1742P Phase II study of rucaparib and atezolizumab (ARIANES): Results in patients (pts) with platinum-sensitive metastatic urothelial cancer (mUC) and metastatic castration-resistant prostate cancer (mCRPC).

20. 1380P High Sonic Hedgehog (HH) signalling activity, low androgen receptor activity and clonal evolution are associated with resistance to androgen-receptor axis inhibitors in patients with metastatic prostate cancer.

22. 726MO Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician's choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775).

23. Obtaining sexual genotypes for breeding in buffel grass.

24. Selecting salt-tolerant clones and evaluating genetic variability to obtain parents of new diploid and tetraploid germplasm in rhodesgrass (Chloris gayana K.)

25. 823P Extended follow-up of a real-world cohort of patients (pts) with BRCA mutation (BRCAm) relapsed epithelial ovarian cancer (EOC) receiving olaparib maintenance therapy: The GINECO RETROLA study.

26. 1565MO Time-dependent improvement in the clinical outcomes from COVID-19 in cancer patients: An updated analysis of the OnCovid registry.

27. 697P Impact of β-blockers (BB) on outcomes of metastatic renal cell carcinoma (mRCC) patients treated with nivolumab (N).

28. 657MO Antibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study.

Catalog

Books, media, physical & digital resources